scholarly article | Q13442814 |
P356 | DOI | 10.1023/A:1015899602741 |
P698 | PubMed publication ID | 2717519 |
P2093 | author name string | D B Lakings | |
J M Friis | |||
J S Mohrland | |||
J T VanderLugt | |||
C M Lunan | |||
P2860 | cites work | Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides | Q28619497 |
Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes | Q42115139 | ||
Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate | Q42246687 | ||
Thromboxanes: selective biosynthesis and distinct biological properties | Q67769711 | ||
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2 | Q67799948 | ||
Liquid chromatographic-ultraviolet methods for furegrelate in serum and urine: preliminary pharmacokinetic evaluation in the dog | Q93607765 | ||
P433 | issue | 1 | |
P921 | main subject | pharmacokinetics | Q323936 |
P304 | page(s) | 53-57 | |
P577 | publication date | 1989-01-01 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Pharmacokinetics of furegrelate after oral administration to normal humans. | |
P478 | volume | 6 |
Q36108052 | Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets | cites work | P2860 |
Search more.